Community cancer Centers' testing practices under review
NCT ID NCT03804255
First seen Jun 24, 2026 · Last updated Jul 17, 2026 · Updated 2 times
Summary
This study aimed to evaluate how community cancer centers test for biomarkers in common solid cancers like breast, lung, and colorectal cancer. Researchers planned to survey pathology practices to see if they follow guidelines for key tests and how quickly results are reported. The goal was to identify gaps and share best practices, but the study was withdrawn before enrolling any participants.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Center for Business Models in Healthcare
Chicago, Illinois, 60625, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Phone-Based navigation could boost breast cancer detection in kenya
- Can new drug cocktails reawaken the immune system against melanoma?
- Could a Six-Month exercise and diet plan shield muscle during melanoma treatment?
- A simple blood draw could spot colorectal cancer early
- Quitting before the knife: which Stop-Smoking aid works best for cancer patients?
- Can a One-Two punch of immune boosters revive cancer treatment?